Showing 1191-1200 of 1614 results for "".
- American Medical Association’s New President a ‘Passionate Defender of the Independent Physician’https://modernod.com/news/american-medical-associations-new-president-a-passionate-defender-of-the-independent-physician/2477875/Susan Bailey, MD, the new president of the American Medical Association (AMA), called for physicians to advocate at the highest levels of government and insurance companies for support needed “to sustain private practice during a pandemic that threatens its very survival,” according t
- Sight Sciences Announces Positive Clinical Results From Trial Evaluating TearCare for the Treatment of Dry Eye Diseasehttps://modernod.com/news/sight-sciences-announces-positive-clinical-results-from-trial-evaluating-tearcare-for-the-treatment-of-dry-eye-disease/2477787/Sight Sciences announced new dry eye clinical data from a multicenter trial of TearCare, the first wearable eyelid technology for dry eye. Data from the study were presented at the American Society of Cataract Refractive Surgery (ASCRS) Virtual annual meeting by Jennifer Loh, MD, practicing ophth
- New COVID-19 Clinical Trial Supported by Octapharma USAhttps://modernod.com/news/new-covid-19-clinical-trial-supported-by-octapharma-usa/2477593/Octapharma USA is supporting a new investigator initiated clinical trial led by George Sakoulas, MD, of Sharp Memorial Hospital in San Diego, focused on treating the most critical patients at the heart of the coronavirus pandemic, those experiencing respiratory failure who become ventilator depen
- Retina Industry Giants Temporarily Extend Payment Termshttps://modernod.com/news/retina-industry-giants-temporarily-extend-payment-terms/2477512/Genentech, Regeneron, Allergan, and Novartis are extending payment terms in response to the COVID-19 crisis. George Williams, MD, discussed the terms of extended payment by Genentech and Regeneron on a recent episode of New Retina Radio, and the details were confirmed by statements from th
- New Retina Radio: Experts Discuss New Patient Protocols in COVID-19 Erahttps://modernod.com/news/new-retina-radio-experts-discuss-new-patient-protocols-in-covid-19-era/2477501/New Retina Radio has launched a new series covering the COVID-19 crisis featuring retina specialists around the world talking about how their practices have been affected. In the first episode of this series, host John W. Kitchens, MD, was j
- Live Webcast: COVID-19 Impact on Retina Practiceshttps://modernod.com/news/live-webcast-covid-19-impact-on-retina-practices/2477468/Bryn Mawr Communications (BMC) will host a live video webcast of its New Retina Radio podcast on Friday at 12 pm ET. The webcast, “How Retina Doctors Are Altering Their Treatments During the COVID-19 Crisis, and How They Can Anticipate What’s Next,” will be hosted by John W. Kitchens, MD. Panelis
- Retina Specialists Share How They Are Adjusting to COVID-19https://modernod.com/news/retina-specialists-share-how-they-are-adjusting-to-covid-19/2477416/As the novel coronavirus outbreak continues to spread in the United States, retina clinics—who often see older patients who are more at risk of virus complications—are making a number of adjustments. Rishi P. Singh, MD, staff physician at the Cole Eye Institute at the Cleveland Clinic, whe
- Orbis International Secures $500,000 Grant for Flying Eye Hospitalhttps://modernod.com/news/orbis-international-secures-500000-grant-for-flying-eye-hospital/2477337/The Conrad N. Hilton Foundation will invest $500,000 to support the sight-saving work Orbis International carries out on its Flying Eye Hospital, the world’s only fully accredited ophthalmic teaching hospital on board an MD-10 aircraft. The one-time gran
- Gyroscope Therapeutics Strengthens Senior Leadership Ahead of Next Stage of Company Growthhttps://modernod.com/news/gyroscope-therapeutics-strengthens-senior-leadership-ahead-of-next-stage-of-company-growth/2477297/Gyroscope Therapeutics announced the strengthening of its leadership team with the hiring of Nadia Waheed, MD, MPH, from Tufts University School of Medicine in Boston as Chief Medical Officer (CMO), and the promotion of Jane Hughes, PhD, formerly VP Translational Research, to Chief Scientific Off
- Aerpio Pharmaceuticals Presents New Data Showing Potential of Topical Ocular Formulation of AKB-9778 When Combined with Prostaglandinhttps://modernod.com/news/aerpio-pharmaceuticals-presents-new-data-showing-potential-of-topical-ocular-formulation-of-akb-9778-when-combined-with-prostaglandin/2477289/Aerpio Pharmaceuticals announced that Kevin Peters, MD, Aerpio’s Chief Scientific Officer, presented data from the fifth cohort of subjects from a phase 1b trial showing the potential of a topical ocular formulation of AKB-9778, a VE-PTP inhibitor and Tie2 activator, to lower IOP with minimal con